Andrew Gengos

Insider Reports History

Location
Bothell, WA
Signature
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Gengos:

Form 4 holding CFO and Chief Business Officer

Athira Pharma, Inc.

Security class
Common Stock
Shares / value
97,532
Estimated value
$55,203
Report date
05 Sep 2024
Price
$0.5660
Ownership
Direct
Form 4 holding CFO and Chief Business Officer

Athira Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
280,000
Estimated value
Report date
14 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Business Officer

Cyteir Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
35,000
Estimated value
Report date
22 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrew Gengos

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .